Stock BIOV BIOVAXYS TECHNOLOGY CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases BioVaxys Technology Corp.

Equities

BIOV

CA09076M1014

Market Closed - Canadian Securities Exchange
Other stock markets
 20:35:54 15/05/2024 BST 		5-day change 1st Jan Change
0.07 CAD -12.50% Intraday chart for BioVaxys Technology Corp. -.--% +40.00%
05-02 Biovaxys Technology Corp. Delays to File Its Interim Financial Statements for the Three Months Ended January 31, 2024 CI
04-30 BioVaxys Technology Corp. Appoints Christopher Cherry as Chief Financial Officer CI

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
BioVaxys Technology Corp. Announces Failure to File Cease Trade Order
AQ
CSE Bulletin: Suspension - BioVaxys Technology Corp. (BIOV)
NE
Canadian Investment Regulatory Organization Trading Halt - BIOV
AQ
BioVaxys Technology Corp. Closes SECOND Tranche of Private Placement
AQ
BioVaxys Technology Corp. Closes First Tranche of Private Placement
AQ
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update
AQ
Biotech Innovations Aim to Combat Soaring Cancer Diagnoses by 2050
AQ
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update
AQ
BIOVAXYS AND SPAYVAC-FOR-WILDLIFE, INC. ANNOUNCE LAUNCH OF FIELD TRIAL FOR LARGE-SCALE IMMUNOCONTRACEPTION IN THE COMMERCIAL AQUATIC FARMING INDUSTRY
AQ
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update
AQ
BIOVAXYS ANNOUNCES PLANNED PRIVATE PLACEMENT
AQ
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update
AQ
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update
AQ
Annual Financial Statements Update for the Year Ended October 31, 2023
AQ
BIOVAXYS COMPLETES THE ACQUISITION OF ALL INTELLECTUAL PROPERTY, IMMUNOTHERAPEUTICS PLATFORM TECHNOLOGY, AND CLINICAL STAGE ASSETS OF THE FORMER IMV INC.
AQ
Canadian Investment Regulatory Organization Trade Resumption - BIOV
AQ
BioVaxys Acquires All Intellectual Property, Immunotherapeutics Platform Technology, and Clinical Stage Assets of the Former IMV Inc.
AQ
Canadian Investment Regulatory Organization Trading Halt - BIOV
AQ
BIOVAXYS ANNOUNCES COMPLETION OF FIRST TRANCHE OF PRIVATE PLACEMENT
AQ
BioVaxys Executes Letter of Intent for Major Immunotherapeutics Technology Acquisition
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BIOV Stock
  4. News BioVaxys Technology Corp.
  5. Press Releases